whose perfectly normal menstrual history practically excludes anorexia nervosa. The same diagnostic reasoning, obviously, cannot be used in thin subjects who have primary amenorrhoea of whatever cause, including XY gonadal dysgenesis.
Secondly, as â€˜¿ body image distortion' is non specific, poorly defined and found in a significant proportion of normal Western females too (Hsu & Sobkiewicz, 1991) , the significance that can be attached to it, in the absence of other convincing anorexic features, is meagre as in the case reported. Besides, other anorexic behaviours such as binge eating, self-induced vomiting or laxative abuse were absent in the patient.
In so far as the exact aetiology ofanorexia nervosa remains unclear and its diagnosis thus depends on the constancy of association of a particular constel lation of clinical features, the above three factors may make the diagnosis ofanorexia nervosa an enig matic one in subjects with XY gonadal dysgenesis and psychopathology. Therefore, while agreeing with the authors that anorexia nervosa, in the syner gistic presence of other psychopathology, may stern from the biological and psychological confusion caused by XY gonadal dysgenesis, I would also like to add a further source of confusion to this potential association, namely, diagnostic confusion. Pru dence, especially among those of us inclined to unearth anorexia nervosa, is suggested.
Methylfolate and psychiatric illness SIR: We would like to echo the comments of Anderson et a! (Journal, January 1992, 160, 130) on the interesting paper by Godfrey et al(l990) concern ing the enhancement of recovery from psychiatric illness by methylfolate.
Apart from the lack of sufficient information regarding changes on the Hamilton Rating Scale for Depression, it should be noted that the use of this scale and the Beck Depression Inventory as a measure of changes in schizophrenic patients (41 % of the total sample) was inappropriate. The lack of correlation was therefore expected. We wondered why more suitable and even simpler scales for this group of patients, such as the Brief Psychiatric Rating Scale, were not used. Instead, only a crude four-point clinical outcome scale was employed. It is quite difficult, for example, to differentiate between a score of â€˜¿ 2' (residual symptoms/socially recovered) and â€˜¿ 3' (pronounced impairment without full social recovery). Furthermore, the baseline ratings of the two groups at month zero were not reported and the question of their comparability remained. Thus, the difference between the methylfolate and placebo groups at one month, as measured by the clinical outcome scale, may partly be due to selection bias, or the initial clinical effect of methylfolate. Finally, the authors did not clearly state whether there was any change in dosage and regime ofmedication or the use of non-pharmacological therapy throughout the trial. This is noteworthy because the clinical outcome scores of the placebo group, for unclear reasons, showed no overall improvement after six months of psychiatric treatment. Instead, both depressed and schizophrenic patients on placebo remained markedly impaired (bordering on score â€˜¿ 3').
Despite their potential importance, folate studies among non-Western populations are virtually non existent. Recently, we measured the folate level of 46
Chinese out-patients on chronic lithium treatment, and found that practically none of them had low within the normal range ofserurn folate (7â€"39 nmol/ 1), patients (n = 14) with a higher serum folate level (33.4 nmol/l) were found to have a lower one-year affective morbidity than those (n = 32) with a lower folate (26.0 nmol/l). This is the first Chinese study to SING LEE strengthen the suggestion that it may be a high rather than normal folate level which is associated with lower psychiatric morbidity (Coppen et a!, 1986 
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Christmas disease and major affective disorder
SIR:We were interested to read Gill et al's description
of a pedigree cosegregating Christmas disease and major affective disorder (Journal, January 1992, 160, 112â€"I 14). We would like to report a further family in which both disorders are segregating. Her eldest son, who is 19 years old, has laboratory proven Christmas disease and DSMâ€"IIIâ€"R major depression and alcohol abuse. The proband's father, who is 67 years old, is haematologically normal but @ had a singleepisode ofDSMâ€"IIIâ€"R major depression at the age of47 years. The proband's mother, who is 68 years old, is a carrier ofthe Christmas disease gene and had a two-year episode of depression at the age of 30 years which necessitated psychiatric referral but which only satisfies DSMâ€"IIIâ€"Rcriteria for depression, not otherwise specified. The proband has @ a haematologically normal son and four daughters who are obligate carriers of the Christmas gene. The proband's sister has two other sons in addition to the one already described: one who has Christmas dis ease and the other who is haematologically normal. None of these seven children has expressed affective disorder but all are below the age of 18 years and, @ thus, they are only starting to approach the risk period.
This pedigree is consistent with genetic linkage between the Christmas disease gene and a suscepti bility locus for affective disorder but does not offer strong support for this hypothesis because of: (a) the small size of the pedigree, and (b) complications in @ interpretation introduced by assortative mating between the proband's parents. Like Dr Gill eta! we which we described carefully and in some detail, was certainly small and unrepresentative, but it is not clear how this fact alone could account for the pattern of findings. He then reproaches us for using correlation rather than regression analysis, omitting to mention that we used partial correlation analysis (regression is based on partial correlations). This con fusion between correlations and partial correlations may also account for his puzzling charge that we had
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